Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

S. Heymans*, L.T. Cooper

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

96 Citations (Web of Science)


The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.
Original languageEnglish
Pages (from-to)75-77
Number of pages3
JournalNature Reviews Cardiology
Issue number2
Early online date9 Dec 2021
Publication statusPublished - Feb 2022

Cite this